成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 13726-69-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 13726-69-7
Chemical Structure| 13726-69-7
Structure of 13726-69-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 13726-69-7 ]

Related Doc. of [ 13726-69-7 ]

Alternatived Products of [ 13726-69-7 ]
Product Citations

Product Details of [ 13726-69-7 ]

CAS No. :13726-69-7 MDL No. :MFCD00053370
Formula : C10H17NO5 Boiling Point : -
Linear Structure Formula :- InChI Key :BENKAPCDIOILGV-RQJHMYQMSA-N
M.W : 231.25 Pubchem ID :88804
Synonyms :

Calculated chemistry of [ 13726-69-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.8
Num. rotatable bonds : 4
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 59.53
TPSA : 87.07 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.53 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.69
Log Po/w (XLOGP3) : 0.25
Log Po/w (WLOGP) : 0.06
Log Po/w (MLOGP) : -0.07
Log Po/w (SILICOS-IT) : -0.64
Consensus Log Po/w : 0.26

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.17
Solubility : 15.7 mg/ml ; 0.068 mol/l
Class : Very soluble
Log S (Ali) : -1.64
Solubility : 5.31 mg/ml ; 0.023 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 0.43
Solubility : 621.0 mg/ml ; 2.69 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.14

Safety of [ 13726-69-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 13726-69-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 13726-69-7 ]

[ 13726-69-7 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 100-39-0 ]
  • [ 13726-69-7 ]
  • [ 40350-83-2 ]
YieldReaction ConditionsOperation in experiment
General procedure: Synthesis of 1m-p 200 mg (0.86 mmol) of (2S,4R), (2S,4S), (2R,4R), or (2R,4S)-Boc-Hyp was dissolved in 3 ml of tetrahydrofuran, cooled to 0 C., and 103 mg (3 eq.) of 60% sodium hydride was added. The mixture was stirred cold for 20 minutes, then 226 ul (2.2 eq) of benzyl bromide was added. The mixture was allowed to warm to room temperature and stirred for 16 hours, at which time it was cooled to 0 C. and 1 ml of water was added, followed by 500 uL of 5% citric acid and 2 mL of saturated sodium bicarbonate solution. The organic layer was separated, and the aqueous phase was washed twice with 1 ml portions of ethyl acetate. The aqueous layer was then acidified to pH2.0 with citric acid, and extracted three times with 2 ml portions of ethyl acetate. The combined organic layers were washed with saturated sodium chloride solution, the solvent removed under reduced pressure, the residues were dissolved in 2 ml of methylene chloride, and 2 ml of 4M HCl in dioxane was added. The mixture was stirred for 12 hours, and the solvent removed under reduced pressure, yielding the HCl salts 3m-p. 300 uM of each was then converted first to 5m-p, then the final product 1m-p as the TFA salt via the methods described earlier for 1h-1.
With sodium hydride; In tetrahydrofuran; mineral oil; at 0℃; for 6h;Reflux; The Boc-protected L-Hyp 3 was dissolved in THF (100mL) and then cannulated into a slurry of NaH (60% inmineral oil, 11.2 g, 155 mmol) in THF (200 mL) at 0 C.Benzyl bromide (15.0 g, 87.7 mmol) was added dropwise tothe reaction mixture. The flask was warmed to room temperatureand then the mixture was heated under reflux for 6h. The reaction mixture was cooled to room temperature andpoured over ice. The organic solvent was evaporated underreduced pressure and the aqueous solution was washed withEtOAc. The aqueous phase was acidified with 2N HCl untilthe pH was 2, and then it was extracted with EtOAc. Theorganic phase was concentrated under reduced pressure toyield 4 as a brownish yellow oil. This brownish yellow oilwas dissolved in dry THF (300 mL) and cooled to 0 C.BH3·DMS (5.7 mL, 58 mmol) was added dropwise to thereaction mixture, which was then kept stirring at 0 C for anadditional 1 h. The flask was removed from the ice bath, andthe mixture stirred overnight at room temperature. Thereaction mixture was poured over ice and sequentiallyextracted with EtOAc, washed with saturated aqueousNaHCO3, washed with brine, and dried (Na2SO4). Thesolution was concentrated under reduced pressure andpurified through flash column chromatography (FCC; gradientEtOAc/hexanes, from 30 to 50%) to yield 5 [26] as aslightly yellow oil (16.3 g, 70% over three steps).
  • 3
  • [ 13726-69-7 ]
  • [ 474417-79-3 ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Pharmaceutical Intermediates of
[ 13726-69-7 ]

Asunaprevir Related Intermediates

Chemical Structure| 24188-74-7

[ 24188-74-7 ]

7-Chloroisoquinolin-1-ol

Chemical Structure| 159622-10-3

[ 159622-10-3 ]

(1R,2S)-1-((tert-Butoxycarbonyl)amino)-2-vinylcyclopropanecarboxylic acid

Chemical Structure| 630423-36-8

[ 630423-36-8 ]

1,7-Dichloro-4-methoxyisoquinoline

Chemical Structure| 940-62-5

[ 940-62-5 ]

(E)-3-(4-Chlorophenyl)acrylic acid

Chemical Structure| 259217-95-3

[ 259217-95-3 ]

(1R,2S)-Ethyl 1-((tert-butoxycarbonyl)amino)-2-vinylcyclopropanecarboxylate

Related Functional Groups of
[ 13726-69-7 ]

Amino Acid Derivatives

Chemical Structure| 87691-27-8

[ 87691-27-8 ]

(2S,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid

Similarity: 1.00

Chemical Structure| 1218998-83-4

[ 1218998-83-4 ]

rel-(2R,4R)-1-(tert-butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid

Similarity: 1.00

Chemical Structure| 147266-92-0

[ 147266-92-0 ]

(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid

Similarity: 1.00

Chemical Structure| 102195-79-9

[ 102195-79-9 ]

(2S,4S)-1-tert-Butyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate

Similarity: 0.95

Chemical Structure|

[ ]

Similarity: 0.95

; ;